Your Source for Venture Capital and Private Equity Financings

Select An Article

Accelsius Closes $65 Million Series B Funding
2026-01-12
AUSTIN, TX, Accelsius, the leader in two-phase, direct-to-chip liquid cooling for AI and high-performance computing, announced the closing of its Series B funding round, raising $65 million.
Read More
Nanochon Closes $4.1M Seed Prime II Funding Round
2026-01-12
WASHINGTON, DC, Nanochon, an orthopedic device company, announced the closing of a $4.1M funding round.
Read More
Soley Therapeutics Inks $200 Million Series C
2026-01-12
SOUTH SAN FRANCISCO, CA, Soley Therapeutics announced a $200 million Series C financing.
Read More
VieCure Secures $43 Million Funding
2026-01-12
GREENWOOD VILLAGE, CO, VieCure, a leading provider of intelligent software platforms for oncology care, has raised $43 million in funding.
Read More
MagicCube Seals $10 Million
2026-01-12
NEW YORK, NY, MagicCube, a software-based security company, announced that it has raised $10 million in committed new funding.
Read More
Neuramint Raises $5M Seed
2026-01-12
DENVER, CO, Neuramint, the leading AI agent platform empowering developers to build and manage autonomous Web3 workflows, announced the successful completion of its $5 million seed funding round.
Read More
Synchrony Medical Inks $1M Funding
2026-01-12
JERSEY CITY, NJ, Synchrony Medical, a respiratory care technology company, announced it has secured additional funding through a $1M investment from the New Jersey Innovation Evergreen Fund.
Read More
Trailhead Biosystems Secures $20 Million
2026-01-12
BEACHWOOD, OH, Trailhead Biosystems, a biotechnology company advancing human cell innovation, has added $20 million in new funding.
Read More
Cytotheryx Nets $60 Million Series A Funding
2026-01-12
ROCHESTER, MN, Cytotheryx, a preclinical cell therapy company developing cell-based treatments for liver disease, announced a $60 million Series A financing.
Read More
EpiBiologics Closes $107M Series B
2026-01-12
SAN MATEO, CA, EpiBiologics, a leader in tissue-selective extracellular protein degradation, announced the completion of a $107 million Series B financing.
Read More
Torq Devours $140M Series D
2026-01-12
DENVER, CO, Torq, the established Agentic AI security operations pioneer, announced it has closed a massive $140 million Series D funding round.
Read More
Diagonal Therapeutics Lands $125 Million Series B
2026-01-12
WATERTOWN, MA, Diagonal Therapeutics, a biotechnology company, announced the closing of an oversubscribed $125 million Series B financing co-led by Sanofi Ventures and Janus Henderson Investors.
Read More
Cast AI Receives Strategic Investment
2026-01-12
MIAMI, FL, Cast AI, the leading Application Performance Automation platform, announced a strategic investment.
Read More
Parabilis Medicines Announces $305M Series F
2026-01-12
CAMBRIDGE, MA, Parabilis Medicines, a clinical-stage biopharmaceutical company, announced the successful closing of a $305 million Series F financing.
Read More